Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 2:39 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1969–1992 of 13,940 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Postoperative Abscess
Interventions: Oxygen Insufflation; Other
Lead sponsor: Chang, Steve S., M.D.; Individual
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Santa Barbara, California

Conditions: Inflammatory Responses
Interventions: 4 g prescription omega-3 concentrate, Placebo; Drug
Lead sponsor: Penn State University; Other
Eligibility: 20 Years to 45 Years · Male only
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Bronchopulmonary Dysplasia (BPD)
Interventions: Benchmarking Management Practices, Standard Management Practices; Other
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 36 Weeks
Enrollment: 4,095 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2004
U.S. locations: 17
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 13 more

Conditions: Delirium, Cognitive Impairment, Critically Ill
Interventions: Sedation,RASS Targeted plus BIS Monitoring, Sedation, RASS Targeted; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Pregnancy, High Risk, Child Development, Post Partum Depression
Interventions: Nurse Family Partnership; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 16 Years to 46 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Suicide, Attempted, Mood Disorders
Interventions: To Share or Not to Share, Peer Support; Behavioral
Lead sponsor: Illinois Institute of Technology; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: COVID-19
Interventions: LY3819253, Placebo, Remdesivir; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 42
States / cities: Tucson, Arizona • Fresno, California • Los Angeles, California + 32 more

Conditions: Central Nervous System Carcinoma
Interventions: Biospecimen Collection, Cognitive Assessment, Magnetic Resonance Imaging, Memantine Hydrochloride, Placebo Administration, Questionnaire Administration; Procedure · Drug · Other
Lead sponsor: Children's Oncology Group; Network
Eligibility: 4 Years to 17 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 137
States / cities: Birmingham, Alabama • Anchorage, Alaska • Mesa, Arizona + 110 more

Conditions: Solid Tumor, Adult, Healthy Donors, COVID-19 Donors
Interventions: Not listed
Lead sponsor: BioCytics, Inc.; Industry
Eligibility: 5 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2030
U.S. locations: 1
States / cities: Huntersville, North Carolina

Conditions: Autistic Disorder
Interventions: methylcobalamin, saline placebo; Drug · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 3 Years to 8 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Scleroderma, Localized, Morphea, Scleroderma, Circumscribed
Interventions: UVA-1 Phototherapy, Placebo; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 6 Years to 95 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Technosphere®/Insulin; Drug
Lead sponsor: Mannkind Corporation; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Chronic Posttraumatic Stress Disorder
Interventions: Revisiting the Trauma memories, Processing the trauma memories, Psychoeducation, Trauma Memory Retrieval Trial, Exposure to video clips related to the patient's trauma, Breathing retraining, Exposure Homework, Compound extinction; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Prevention of Subclinical Atherosclerosis Progression, Prevention of Cognitive Decline
Interventions: Nattokinase, Placebo; Dietary Supplement · Other
Lead sponsor: University of Southern California; Other
Eligibility: 55 Years to 100 Years
Enrollment: 265 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cystic Fibrosis
Interventions: Self-Regulated Exercise with Telephone Reinforcement, Standard Treatment, Qualitative Approach; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 10 Years to 18 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Schizophrenia, Fatty Acid Deficiency
Interventions: Omega-3 Fatty Acids, Olive oil placebo, EPA fish oil concentrate; DHA fish oil concentrate, Placebo; Dietary Supplement · Other · Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 8 Years to 25 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Crohn's Disease, Vitamin D Deficiency
Interventions: Cholecalciferol 10,000 IU, Cholecalciferol 400 IU; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 75 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 4
States / cities: Indianapolis, Indiana • Iowa City, Iowa • Ann Arbor, Michigan + 1 more

Conditions: Osteoarthritis
Interventions: PH-797804, Placebo, Naproxen, Naproxen + PH-797804; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 26
States / cities: Paramount, California • Spring Valley, California • Valley Village, California + 20 more

Conditions: Patient Satisfaction, Sports Injury, Surgery, Orthopedic Disorder
Interventions: virtual phone appointment visits; Other
Lead sponsor: Jonathan Wu; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Torrance, California

Conditions: Acute Myeloid Leukemia
Interventions: Fludarabine, Cytarabine, Gemtuzumab Ozogamicin, Azacitidine, Venetoclax; Drug
Lead sponsor: PedAL BCU, LLC; Other
Eligibility: 29 Days to 21 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2031
U.S. locations: 45
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Long Beach, California + 40 more

Conditions: Coronary Disease
Interventions: CoStar Paclitaxel Drug Eluting Coronary Stent System, TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent; Device
Lead sponsor: Cordis US Corp.; Industry
Eligibility: 18 Years and older
Enrollment: 1,701 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 2
States / cities: Durham, North Carolina • Cincinnati, Ohio

Conditions: Cancer Pain, Oncology, Virtual Reality, Depression, Anxiety
Interventions: Virtual Reality Assisted Guided Imagery (VRAGI); Behavioral
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 18 Years to 65 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 3
States / cities: Clemson, South Carolina • Columbia, South Carolina • Greenville, South Carolina

Conditions: Nicotine Dependence
Interventions: Selegiline Transdermal Patch, Placebo, Smoking Cessation Counseling; Drug · Behavioral
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 246 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 4
States / cities: College Park, Maryland • New Brunswick, New Jersey • Cincinnati, Ohio + 1 more

Conditions: Anorexia, Cachexia, Fatigue, Lung Cancer
Interventions: infliximab, docetaxel, placebo; Biological · Drug · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 188
States / cities: Scottsdale, Arizona • Aurora, Colorado • Boulder, Colorado + 116 more

Search by objective public record fields.

Oxygen Insufflation To Reduce Postoperative Abscess In Laparoscopic Appendectomy

Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation

Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia

The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status

Nurse Family Partnership for Women With Previous Live Births

Strategic Disclosure Intervention for Suicide Attempt Survivors

LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Efficacy Study of Subcutaneous Methyl-B12 in Children With Autism

Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea

A Study to Evaluate Insulin in the Blood After Inhalation of a Dry Powder Insulin Formulation (Called Technosphere®/Insulin) in Non-diabetic Patients With & Without Chronic Obstructive Pulmonary Disease (COPD)

Enhancing Exposure Therapy for Post-traumatic Stress Disorder

Nattokinase Atherothrombotic Prevention Study

Exercise Training Study for Patients With Cystic Fibrosis

Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia

Trial of High Dose Vitamin D in Patient's With Crohn's Disease

Clinical Trial to Examine the Pain Relief of PH-797804 Alone Or With Naproxen in Subjects With Osteoarthritis of the Knee

Virtual Phone Visits Compared to In-Person Physical Visits for Post-Operative Follow-Up at a Sports Medicine Clinic

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

Randomized Controlled Trial of Virtual Reality Assisted Guided Imagery (VRAGI) for Pain in Advanced Cancer Patients.

Selegiline for Smoking Cessation - 1

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)